ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979